Purification and characterization of fimbriae isolated from Bordetella pertussis
- PMID: 2859248
- PMCID: PMC261332
- DOI: 10.1128/iai.48.2.422-427.1985
Purification and characterization of fimbriae isolated from Bordetella pertussis
Abstract
Fimbriae were detached from Bordetella pertussis by mechanical shearing and purified by successive precipitations with ammonium sulfate, phosphate buffer (pH 6.0), and magnesium chloride. In each of these purification steps, the fimbriae aggregated into bundles as seen by electron microscopy. These aggregates could be disaggregated at pH 9.5. By electron microscopy, the purified fimbriae appeared as long filaments with a diameter of 5 nm. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the purified fimbriae showed a single protein subunit with a molecular weight of 22,000. The purified fimbriae did not have hemagglutinating activity when assayed with several types of erythrocytes, and they were antigenically, chemically, and structurally distinct from the filamentous hemagglutinin of B. pertussis. The purified fimbriae were also identified as serotype 2 agglutinogens, since antibody to the purified fimbriae agglutinated B. pertussis strains serotyped as 1.2.4, 1.2.3, or 1.2.3.6 but did not agglutinate those serotyped as 1.3.6.
Similar articles
-
Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.Dev Biol Stand. 1985;61:173-85. Dev Biol Stand. 1985. PMID: 2872103
-
Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae.Infect Immun. 1987 Apr;55(4):916-22. doi: 10.1128/iai.55.4.916-922.1987. Infect Immun. 1987. PMID: 2881893 Free PMC article.
-
Release and purification of fimbriae from Bordetella pertussis.Dev Biol Stand. 1985;61:153-63. Dev Biol Stand. 1985. PMID: 2872101
-
Serotyping Bordetella pertussis strains.Vaccine. 1989 Dec;7(6):491-4. doi: 10.1016/0264-410x(89)90270-3. Vaccine. 1989. PMID: 2575308 Review.
-
Bordetella pertussis fimbriae (Fim): relevance for vaccines.Expert Rev Vaccines. 2014 Oct;13(10):1205-14. doi: 10.1586/14760584.2014.930667. Epub 2014 Aug 8. Expert Rev Vaccines. 2014. PMID: 25102891 Review.
Cited by
-
Purification and subunit heterogeneity of pili of Bordetella bronchiseptica.Infect Immun. 1986 Feb;51(2):586-93. doi: 10.1128/iai.51.2.586-593.1986. Infect Immun. 1986. PMID: 2867974 Free PMC article.
-
Helical structure of Bordetella pertussis fimbriae.J Bacteriol. 1986 Sep;167(3):968-74. doi: 10.1128/jb.167.3.968-974.1986. J Bacteriol. 1986. PMID: 2875062 Free PMC article.
-
Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation.EMBO J. 1990 Sep;9(9):2803-9. doi: 10.1002/j.1460-2075.1990.tb07468.x. EMBO J. 1990. PMID: 1975238 Free PMC article.
-
Activation of complement receptor 3 on human monocytes by cross-linking of very-late antigen-5 is mediated via protein tyrosine kinases.Immunology. 1999 Oct;98(2):197-202. doi: 10.1046/j.1365-2567.1999.00871.x. Immunology. 1999. PMID: 10540218 Free PMC article.
-
Localization of high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae by immunoelectron microscopy.Infect Immun. 1994 Oct;62(10):4460-8. doi: 10.1128/iai.62.10.4460-4468.1994. Infect Immun. 1994. PMID: 7927710 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources